Genetics Report
: Analysis on the Market, Trends, and TechnologiesThe genetics business domain is marked by a robust and diverse ecosystem comprising over 51,000 companies engaged in a variety of activities from R&D and IT services to health and wellness, biotechnology, and more. The sector is witnessing a surge in interest and investment, with a significant increase in funding despite a decline in news coverage growth. Key trends include advancements in DNA sequencing, gene editing, and biotechnology, which are contributing to the sector’s evolution. Despite a decrease in the growth of new companies and news coverage, the genetics field remains a critical area in the business landscape, showing promise for innovation and growth.
We updated this report 5 days ago. Missing information? Contact us to add your insights.
Topic Dominance Index of Genetics The Topic Dominance Index takes a comprehensive approach to analyzing the evolution of Genetics. The trendline combines the share of voice distributions of the topic from 3 data sources: published articles, founded companies, and global search. The combined distribution is measured over the last 5 years and shows relative dominance of Genetics to all known Trends and Technologies.
Key Activities and Applications
- Research and development in genetic sequencing and gene therapy.
- Information technology services integrating genetics data.
- Health and wellness programs tailored to genetic profiles.
- Biotechnological advancements in personalized medicine and agriculture.
- Development and commercialization of molecular diagnostic solutions.
Emergent Trends and Core Insights
- Growing interest in personalized medicine driven by genetic understanding.
- Expansion of biotechnological applications in healthcare and agriculture.
- Positive investment growth reflecting confidence in the genetics sector.
- Advancements in gene editing technologies like CRISPR.
- Increasing relevance of genetics in media and publications.
Technologies and Methodologies
- DNA sequencing technologies for understanding genetic makeup.
- CRISPR and other gene editing tools for therapeutic developments.
- Artificial intelligence and machine learning in genomic data analysis.
- Cloud-based platforms for genomic data sharing and collaboration.
- Non-invasive diagnostic tests for genetic disorders.
Genetics Funding
A total of 7.6K Genetics companies have received funding.
Overall, Genetics companies have raised $475.1B.
Companies within the Genetics domain have secured capital from 19.9K funding rounds.
Genetics Companies
TrendFeedr's Companies feature provides access to millions of detailed company profiles. The feature gives a better understanding of 51.4K companies that drive Genetics, how mature and well-funded these companies are.
51.4K Genetics Companies
Discover Genetics Companies, their Funding, Manpower, Revenues, Stages, and much more
Genetics Investors
Gain insights into 6.0K Genetics investors and investment deals. TrendFeedr’s investors tool presents an overview of investment trends and activities, helping create better investment strategies and partnerships.
6.0K Genetics Investors
Discover Genetics Investors, Funding Rounds, Invested Amounts, and Funding Growth
Genetics News
Gain a competitive advantage with access to 239.2K Genetics articles with TrendFeedr's News feature. The tool offers an extensive database of articles covering recent trends and past events in Genetics. This enables innovators and market leaders to make well-informed fact-based decisions.
239.2K Genetics News Articles
Discover Latest Genetics Articles, News Magnitude, Publication Propagation, Yearly Growth, and Strongest Publications
Executive Summary
The genetics sector is experiencing dynamic growth and innovation, with significant investments fueling advancements in gene therapy, personalized medicine, and biotechnology. The sector's ability to adapt and integrate new technologies and methodologies underscores its potential for continued development and its pivotal role in shaping the future of healthcare and agriculture. Despite challenges in news coverage and the establishment of new companies, the genetics domain remains a vital and promising field, poised for breakthroughs that could revolutionize medical treatment and enhance global health.
Interested in contributing your expertise on trends and tech? We’d love to hear from you.
